E. P. Krenning

2.6k total citations
44 papers, 2.0k citations indexed

About

E. P. Krenning is a scholar working on Epidemiology, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, E. P. Krenning has authored 44 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 13 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in E. P. Krenning's work include Neuroendocrine Tumor Research Advances (19 papers), Radiopharmaceutical Chemistry and Applications (12 papers) and Neuroblastoma Research and Treatments (7 papers). E. P. Krenning is often cited by papers focused on Neuroendocrine Tumor Research Advances (19 papers), Radiopharmaceutical Chemistry and Applications (12 papers) and Neuroblastoma Research and Treatments (7 papers). E. P. Krenning collaborates with scholars based in Netherlands, Switzerland and United States. E. P. Krenning's co-authors include Willem H. Bakker, D. J. Kwekkeboom, Steven W. J. Lamberts, R. Docter, H.Y. Oei, Jean Claude Reubi, G. Hennemann, P.P.M. Kooij, A Mulder and Dion Paridaens and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Endocrinology.

In The Last Decade

E. P. Krenning

44 papers receiving 1.9k citations

Peers

Countries citing papers authored by E. P. Krenning

Since Specialization

Citations

This map shows the geographic impact of E. P. Krenning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. P. Krenning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. P. Krenning more than expected).

Fields of papers citing papers by E. P. Krenning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. P. Krenning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. P. Krenning. The network helps show where E. P. Krenning may publish in the future.

Co-authorship network of co-authors of E. P. Krenning

This figure shows the co-authorship network connecting the top 25 collaborators of E. P. Krenning. A scholar is included among the top collaborators of E. P. Krenning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. P. Krenning. E. P. Krenning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular imaging of reduced renal uptake of radiolabelled [DOTA0,Tyr3]octreotate by the combination of lysine and Gelofusine in rats 2008 ·Nuklearmedizin - NuclearMedicine ·Bert F. Bernard, Wout A. P. Breeman, Flavio Forrer, Erik de Blois, Jack Hoppin, Martin Gotthardt, Otto C. Boerman, E. P. Krenning, Marion de Jong, Edgar J. Rolleman	40
2	Radiolabelled Regulatory Peptides for Imaging and Therapy 2007 ·Anti-Cancer Agents in Medicinal Chemistry ·Marion de Jong, T.J. Visser, Erik de Blois, Wout A. P. Breeman, D. J. Kwekkeboom, E. P. Krenning	33
3	Clinical Practice of Molecular Radiotherapy 2007 ·Steven M. Larson, E. P. Krenning, Rodolfo Núñez	1
4	Comparison of [177Lu-DOTA0,Tyr3]octreotate and [177Lu-DOTA0,Tyr3]octreotide: which peptide is preferable for PRRT? 2006 ·European Journal of Nuclear Medicine and Molecular Imaging ·Jan-Paul Esser, E. P. Krenning, Jaap J.M. Teunissen, P.P.M. Kooij, (unknown), Willem H. Bakker, Dik J. Kwekkeboom	132
5	Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer 2003 ·European Journal of Nuclear Medicine and Molecular Imaging ·M. Visser, (unknown), A. Srinivasan, Jean Claude Reubi, Beatrice Waser, Jack L. Erion, Michelle Schmidt, E. P. Krenning, M. de Jong	78
6	The role of octreotide scintigraphy in rheumatoid arthritis and sarcoidosis. 2003 ·PubMed ·Virgil A. S. H. Dalm, P. Martin van Hagen, E. P. Krenning	12
7	Controlled introduction of the sentinel node biopsy in breast cancer in a multi-centre setting: the role of a coordinator for quality control 2000 ·European Journal of Surgical Oncology ·A.Y. de Kanter, A.N. van Geel, M.A. Paul, Casper H.J. van Eijck, S.C. Henzen‐Logmans, R. H. Kruyt, E. P. Krenning, Alexander M.M. Eggermont, Theo Wiggers	20
8	Somatostatin Receptor Scintigraphy in Non-Medullary Thyroid Cancer 1996 ·Digestion ·P.T.E. Postema, Wouter W. de Herder, Jean Claude Reubi, H.Y. Oei, D. J. Kwekkeboom, (unknown), Jaap Bonjer, Hans van Toor, G. Hennemann, E. P. Krenning	37
9	An unusual case of multiple endocrine neoplasia type 1 and the role of In-pentetreotide scintigraphy 1996 ·The Netherlands Journal of Medicine ·(unknown), (unknown), H. J. Bonjer, Carla Wauters, E. P. Krenning, Steven W. J. Lamberts	2
10	Somatostatin analogue scintigraphy in granulomatous diseases 1994 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), E. P. Krenning, J.C. Reubi, D. J. Kwekkeboom, Willem H. Bakker, A Mulder, (unknown), (unknown), Steven W. J. Lamberts	118
11	Somatostatin-receptor scintigraphy in primary breast cancer 1994 ·The Lancet ·Casper H.J. van Eijck, J Jeekel, E. P. Krenning, Aart H. Bootsma, Steven W. J. Lamberts, H.Y. Oei, Jan Lindemans, Renée van Pel, Jean Claude Reubi	98
12	Acromegaly and hyperprolactinemia in a patient with polyostotic fibrous dysplasia: Dynamic endocrine studies and treatment with the somatostatin analogue octreotide 1994 ·Journal of Endocrinological Investigation ·(unknown), H. P. F. Koppeschaar, (unknown), J.H.H. Thijssen, E. P. Krenning	11
13	Somatostatin analogue scintigraphy in carcinoid tumours 1993 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), E. P. Krenning, Willem H. Bakker, H.Y. Oei, (unknown), S. W. J. Lamberts	139
14	The importance of thyroid microsomal antibodies in the development of elevated serum TSH in middle‐aged women: associations with serum lipids 1993 ·Clinical Endocrinology ·(unknown), (unknown), D. E. Grobbee, R. Docter, A. M. De Bruyn, (unknown), J. P. van der Merwe, Albert M. van Hemert, E. P. Krenning, G. Hennemann, R. F. A. Weber	98
15	Somatostatin receptor imaging in vivo localization of tumors with a radiolabeled somatostatin analog 1990 ·The Journal of Steroid Biochemistry and Molecular Biology ·Steven W. J. Lamberts, Willem H. Bakker, J.C. Reubi, E. P. Krenning	18
16	Development and Use of a Mathematical Two-Pool Model of Distribution and Metabolism of 3,3′,5-Triiodothyronine in a Recirculating Rat Liver Perfusion System: Albumin Does not Play a Role in Cellular Transport* 1990 ·Endocrinology ·R. Docter, Marion de Jong, (unknown), E. P. Krenning, G Hennemann	13
17	Pulmonary clearance of 99mTc‐DTPA during halothane anaesthesia 1990 ·Acta Anaesthesiologica Scandinavica ·Per Wollmer, (unknown), J. A. H. Bos, WAYNE BARKER, E. P. Krenning, Burkhard Lachmann	30
18	Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biologic activity, and in vivo application in animals. 1990 ·PubMed ·Willem H. Bakker, E. P. Krenning, (unknown), (unknown), P.P.M. Kooij, (unknown), (unknown), T. J. Visser, R. Docter, S.W.J. Lamberts	123
19	Effects of immunoscintigraphy with monoclonal antibodies in assays of hormones and tumour markers. 1989 ·BMJ ·J. A. M. J. L. Janssen, P. J. Blankestijn, R. Docter, B. G. Blijenberg, T. A. W. Splinter, Hans van Toor, Maarten A.D.H. Schalekamp, Steven W. J. Lamberts, E. P. Krenning	12
20	Multiple endocrine neoplasia syndrome type 2: The value of screening and central registration 1987 ·The American Journal of Medicine ·Hans F. A. Vasen, A. C. Nieuwenhuijzen Kruseman, Hans J. Berkel, (unknown), (unknown), (unknown), R. A. Geerdink, Harm R. Haak, Wil H.L. Hackeng, H. P. F. Koppeschaar, E. P. Krenning, Steven W. J. Lamberts, (unknown), Robert P.J. Michels, (unknown), Gerlach F. Pieters, Wilmar M. Wiersinga, C.J.M. Lips	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact